| NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts X Fan, L Khaki, TS Zhu, ME Soules, CE Talsma, N Gul, C Koh, J Zhang, ... Stem Cells 28 (1), 5-16, 2009 | 789 | 2009 |
| Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis B Gurel, T Iwata, CM Koh, RB Jenkins, F Lan, C Van Dang, JL Hicks, ... Modern Pathology 21 (9), 1156-1167, 2008 | 493 | 2008 |
| MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis CM Koh, M Bezzi, DHP Low, WX Ang, SX Teo, FPH Gay, M Al-Haddawi, ... Nature, 2015 | 374 | 2015 |
| MYC and prostate cancer CM Koh, CJ Bieberich, CV Dang, WG Nelson, S Yegnasubramanian, ... Genes & cancer 1 (6), 617-628, 2010 | 361 | 2010 |
| Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms CM Koh, T Iwata, Q Zheng, C Bethel, S Yegnasubramanian, AM De Marzo Oncotarget 2 (9), 669, 2011 | 192 | 2011 |
| Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation H Ji, G Wu, X Zhan, A Nolan, C Koh, A De Marzo, HM Doan, J Fan, ... PloS one 6 (10), e26057, 2011 | 191 | 2011 |
| Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity CM Koh, E Khattar, SC Leow, CY Liu, J Muller, WX Ang, Y Li, G Franzoso, ... The Journal of clinical investigation 125 (125 (5)), 0-0, 2015 | 165 | 2015 |
| Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth M Dewaele, T Tabaglio, K Willekens, M Bezzi, SX Teo, DHP Low, CM Koh, ... The Journal of Clinical Investigation 126 (1), 0-0, 2015 | 163 | 2015 |
| MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3. 1 in mouse luminal epithelial cells T Iwata, D Schultz, J Hicks, GK Hubbard, LN Mutton, TL Lotan, C Bethel, ... PloS one 5 (2), e9427, 2010 | 147 | 2010 |
| Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene CM Koh, B Gurel, S Sutcliffe, MJ Aryee, D Schultz, T Iwata, M Uemura, ... The American journal of pathology 178 (4), 1824-1834, 2011 | 132 | 2011 |
| Iron-responsive degradation of iron-regulatory protein 1 does not require the Fe–S cluster SL Clarke, A Vasanthakumar, SA Anderson, C Pondarré, CM Koh, ... The EMBO journal 25 (3), 544-553, 2006 | 113 | 2006 |
| Targeting MYC in cancer therapy: RNA processing offers new opportunities CM Koh, A Saḅ, E Guccione BioEssays, 2016 | 96 | 2016 |
| Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic and Therapeutic Targets B Gurel, T Iwata, C Koh, S Yegnasubramanian, WG Nelson, AM De Marzo Advances in anatomic pathology 15 (6), 319, 2008 | 94 | 2008 |
| Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation M Uemura, Q Zheng, CM Koh, WG Nelson, S Yegnasubramanian, ... Oncogene 31 (10), 1254-1263, 2012 | 86 | 2012 |
| Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants H Asano, CY Lee, K Fox-Talbot, CM Koh, MM Erdinc, S Marschner, S Keil, ... Transplantation 84 (9), 1174-1182, 2007 | 72 | 2007 |
| Preparation of Cells for Microscopy using Cytospin. CM Koh Methods in enzymology 533, 235-240, 2012 | 43 | 2012 |
| The Where and the How of PRMT5 CM Koh, M Bezzi, E Guccione Current Molecular Biology Reports 1 (1), 19-28, 2015 | 30* | 2015 |
| Isolation of Genomic DNA from Mammalian Cells CM Koh DOI 10, 161, 2013 | 23 | 2013 |
| Storage of bacteria and yeast. CM Koh Methods in enzymology 533, 15-21, 2012 | 19 | 2012 |
| Preparation of Cells for Microscopy using Chamber Slides and Coverslips. CM Koh Methods in enzymology 533, 241-247, 2012 | 7 | 2012 |
